JFS Wealth Advisors’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-1
Closed -$5 1938
2025
Q3
$5 Hold
1
﹤0.01% 1900
2025
Q2
$5 Sell
1
-3
-75% -$13 ﹤0.01% 1865
2025
Q1
$18 Hold
4
﹤0.01% 1923
2024
Q4
$19 Sell
4
-2
-33% -$11 ﹤0.01% 1931
2024
Q3
$42 Hold
6
﹤0.01% 1935
2024
Q2
$47 Hold
6
﹤0.01% 1960
2024
Q1
$43 Buy
6
+1
+20% +$7 ﹤0.01% 1983
2023
Q4
$34 Sell
5
-1
-17% -$6 ﹤0.01% 1985
2023
Q3
$34 Hold
6
﹤0.01% 1943
2023
Q2
$34 Hold
6
﹤0.01% 1961
2023
Q1
$38 Buy
+6
New +$33 ﹤0.01% 1930
2021
Q1
Sell
-85
Closed -$3K 603
2020
Q4
$3K Buy
+85
New +$3.9K ﹤0.01% 509

Other funds holding GDRX

JFS Wealth Advisors's GDRX Position: Q4 2025 in Review

JFS Wealth Advisors sold out of GoodRx Holdings (GDRX) in Q4 2025, closing a stake of 1 share — an estimated $5 sold.

JFS Wealth Advisors first reported a position in GDRX in Q4 2020 and held it in 12 quarters. The position peaked at $3K in Q4 2020. 183 funds tracked by Wall St. Rank hold GDRX as of Q4 2025.

  • JFS Wealth Advisors reported no remaining GoodRx Holdings position as of Q4 2025 after selling out during the quarter.
  • JFS Wealth Advisors sold 1 GoodRx Holdings share in Q4 2025, an estimated $5.
  • JFS Wealth Advisors first reported a position in GoodRx Holdings in Q4 2020 and held it in 12 quarters.
  • JFS Wealth Advisors's GoodRx Holdings position peaked at $3K in Q4 2020.
  • 183 funds tracked by Wall St. Rank held GoodRx Holdings as of Q4 2025.

Based on JFS Wealth Advisors's 13F filing for Q4 2025, filed 14 Jan 2026.